Human Genome Sciences autoimmune, cancer news

Human Genome said it will reduce headcount by 101 (8%) to about 1,200. The cuts will come from manufacturing, R&D and administration.

Read the full 221 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE